CDC Says Overweight People Need Longer Needles for Vaccinations
If you were among the many who experienced a breakthrough SARS-CoV-2 infection despite getting a COVID-19 shot (or two or three), federal health officials suggest that—if you are overweight or obese—the length of the needle used to inject you might be to blame, not vaccine failure. New recommendations from the U.S. Centers for Disease Control […]
Merck’s COVID Anti-Viral Drug May Cause SAR-CoV-2 to Mutate
Scientists have found evidence to suggest that an anti-viral COVID-19 drug manufactured by Merck & Co. being used to treat COVID may be causing the SARS-CoV-2 virus to mutate and create new variants of the virus for which humans could have no immunity.1 The mechanism of action of the drug molnupiravir, a pill also sold […]
Nobel Prize Goes to Dubious mRNA Research Used to Develop COVID Shots
On Oct. 2, 2023, the Nobel Assembly at Karolinska Institutet in Stockholm, Sweden awarded the 2023 Nobel Prize in Physiology or Medicine jointly to scientists Katalin Karikó, PhD and Drew Weissman, MD, PhD “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.” The mRNA (messenger RNA) “vaccines”—which […]
These Endless Coronavirus Mutations
Shortly after the global campaign to control infection with the SARS-CoV-2 virus using mRNA COVID-19 shots began in the United States on Dec. 14, 2020, one of the concerns expressed by some scientists and doctors was that mass use of the bioengineered products might cause the virus to mutate and lead to variants and subvariants, […]
Novel mRNA Lyme Shots Could Be Released in 2025
Two novel messenger RNA (mRNA) shots for Lyme disease currently in late-stage clinical trials could hit the market as early as 2025, Moderna announced earlier this year. Also in the race to develop the first-ever mRNA product to prevent Lyme disease are Pfizer and Austria-based Valneva, which entered into a collaborative agreement in April 2020 […]
FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine
On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]
